NCT07207642

Brief Summary

As the Alzheimer's disease progresses, caregivers and family members often focus on behavioral difficulties. In response to crises, immediate actions tend to favor restraints, either through medication or physical means. This work aims to improve the management of behavioral disturbances in patients with Alzheimer's disease through musical interventions (group or individual), particularly in advanced stages of the disease, where medical and family resources are insufficient. The investigators approach prioritizes NTM over medication as a mean to improve patient well-being. To this end, they have designed a study. The study focuses on creating a conducive environment for sleep by incorporating ritualized, familiar music sessions supervised by nursing staff after meals. To conduct this study, the actigraphy will be used to analyze participants' behavior both day and night, complemented by questionnaires and clinical observations.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
18mo left

Started Jan 2026

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Jan 2026Feb 2028

First Submitted

Initial submission to the registry

June 18, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

October 6, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

January 13, 2026

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2028

Last Updated

January 26, 2026

Status Verified

January 1, 2026

Enrollment Period

1.8 years

First QC Date

June 18, 2025

Last Update Submit

January 23, 2026

Conditions

Keywords

Alzheimer's diseaseMusic interventionBehavior disorder

Outcome Measures

Primary Outcomes (1)

  • Sleep duration

    Sleep duration will be measured by actigraphy (bracelet worn by the participants).

    Days 1 to 51

Secondary Outcomes (4)

  • Sleep onset and nocturnal awakenings reduction

    Days 1 to 51

  • Daytime agitation reduction

    Days 1 to 51

  • Mood improvement

    Days 1 to 51

  • Falls number reduction

    Days 1 to 51

Study Arms (2)

Passive EXPERIMENT

Measurement of the effects of a personalised music listening session at bedtime (play-list) for 10 days. Each patient is his or her own control. Behavioural and actigraphic data are collected and compared before, during and after the intervention.

Behavioral: Music intervention - passive listening

Active EXPERIMENT

An intervention based on listening to audio books, led by a therapist for 10 evenings . Each patient is his or her own control and takes part in the entire experiment. Behavioural and actigraphic data are collected and compared before, during and after intervention.

Behavioral: Audio books intervention - active listening

Interventions

Diffusion of familiar music in the bedrooms and living room before bedtime; passive and individual listening.

Passive EXPERIMENT

Dynamic audio book listening, akin to active listening while respecting the rhythm of the evening . This type of listening involves concentrating specifically .

Active EXPERIMENT

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients aged 60 and over, meeting the diagnostic criteria for Alzheimer's disease and related disorders, living in a Protected Living Unit (PLU) will be included.

You may qualify if:

  • Non-opposition of the patient's legal guardian.
  • Patients aged 60 and over, meeting the diagnostic criteria for Alzheimer's disease and related disorders.
  • Patients living in a Protected Living Unit (PLU)
  • If consuming psychotropic medications, they must have been stabilized for 3 months.
  • If consuming level 2 or 3 analgesics, they must have been stabilized for 1 month.

You may not qualify if:

  • Refusal to participate.
  • Participation in a study on a drug /medical device / care technique that could affect sleep or behavior during the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Saint-Etienne

Saint-Etienne, France, 42100, France

RECRUITING

MeSH Terms

Conditions

Alzheimer DiseaseMental Disorders

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive Disorders

Study Officials

  • Isabelle ROUCH, Md

    CHU de Saint-Etienne

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2025

First Posted

October 6, 2025

Study Start

January 13, 2026

Primary Completion (Estimated)

November 1, 2027

Study Completion (Estimated)

February 1, 2028

Last Updated

January 26, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations